EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The role of flow cytometric assessment of TRBC1/2 expression in ruling out hematologic malignancy in a patient with EBV/CMV induced lymphoproliferation: A case report

Georgi Vasilev, Rositsa Vladimirova, Maria Muhtarova, Milan Jagurinoski, Margarita Guenova

Immunology in Medicine · 13.07.2026 · 19 (1) · 1-6

DOI: 10.3897/im.19.e202240 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Immunology in Medicine, online erschienen am 13.07.2026. Verfasst von Georgi Vasilev und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In a clinical setting, some atypical cases of mononucleosis accompanied by marked lymphocytosis featuring atypical pleomorphic morphology and lymphadenomegaly, raise hematological red flags and could  create a diagnostic challenge. Case presentation:  We report a case of an 18-year-old male presenting with bilateral lymphadenopathy limited to the cervical region, and significant absolute lymphocytosis (12.12 x109/L). Biochemical markers showed elevated  LDH and transaminases, while virological analysis confirmed concurrent primary EBV and CMV infection, but lacked the classical EBV-associated triad: fever, pharyngitis and generalized lymphadenomegaly. Morphological assessment of the peripheral blood ident ified atypical lymphocytes. Multiparametric flow cytometry revealed a massive expansion of activated (CD38+/HLA-DR+) CD8+ T-cytotoxic lymphocytes with a severely inverted CD4/CD8 ratio of 0.1. The definitive exclusion of malignancy was achieved using the n ovel TCRβC1/TCRβC2 flow cytometric analysis, which demonstrated a polytypic distribution (38%/59%), confirming a reactive polyclonal proliferation.

Conclusion

Integrated diagnostic approaches are essential in cases of significant viral-induced lymphocytos is. TCRβC1/2 typing serves as a rapid and objective tool to confirm polyclonality, allowing for the early exclusion of T-cell neoplasms and the definitive diagnosis of reactive lymphoproliferation . 

Zitieren

APA

Vasilev, G., Vladimirova, R., Muhtarova, M., Jagurinoski, M., & Guenova, M. (2026). The role of flow cytometric assessment of TRBC1/2 expression in ruling out hematologic malignancy in a patient with EBV/CMV induced lymphoproliferation: A case report. Immunology in Medicine, 19(1), 1-6. https://doi.org/10.3897/im.19.e202240

Vancouver

Vasilev G, Vladimirova R, Muhtarova M, Jagurinoski M, Guenova M. The role of flow cytometric assessment of TRBC1/2 expression in ruling out hematologic malignancy in a patient with EBV/CMV induced lymphoproliferation: A case report. Immunology in Medicine. 2026;19(1):1-6. doi:10.3897/im.19.e202240

BibTeX
@article{Vasilev2026,
  author = {Vasilev, Georgi and Vladimirova, Rositsa and Muhtarova, Maria and Jagurinoski, Milan and Guenova, Margarita},
  title = {The role of flow cytometric assessment of TRBC1/2 expression in ruling out hematologic malignancy in a patient with EBV/CMV induced lymphoproliferation: A case report},
  journal = {Immunology in Medicine},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {1--6},
  doi = {10.3897/im.19.e202240}
}
Kostenlos starten →